Are you a healthy person? Have you wanted to get involved in clinical research in lung diseases? If so, you can join our registry list of interested individuals through a quick online form. We will give you a call if there are studies that you may be eligible for.

This study will look at how adultd with severe asthma are managed and how asthma affects their well-being.

Do you have COPD and repeated breathing flares ending up in the hospital? If you are under the care of a doctor at UNC, you may be eligible for a research study to find out which of two medicines, roflumilast or azithromycin, can help your COPD control.

The purpose of this study is to measure the strength of breaths in patients with COPD using a device that mimics different inhalers.

Researchers are looking for current and former smokers with or without COPD to enroll in a registry to be contacted for future studies.

This study is testing a new medication for patients who have group 1 PAH.

The purpose of this study is to evaluate a new test being developed by Tempus for patients with Non-Small Cell Lung Cancer (NSCLC). The goal of this new test is to predict the likelihood of a patient's cancer coming back after treatment, and to further explore changes in patient's tumors throughout treatment to see how they respond.

The study is testing a new medication for PH-COPD. The hope is this drug improves patient's overall health outcomes.

This study wants to test a inhaled version of an already approved medication for pulmonary hypertension (PH). The purpose is to test its safety and tolerability in group 1 and group 3 PH patients.

There is a movement toward addressing social risk factors as part of healthcare delivery, with similar efforts launched by the CF Foundation. However, current social screening tools do not capture the unique risks and needs of people with CF, have not been tailored to adults with CF vs caregivers of children with CF, and have not been adapted to multidisciplinary CF care delivery. Our work also showed <20% of those who report needs access help, and found barriers related to stigma, guilt, or fear. It is critical to develop a social screening instrument that is specific to adults and caregivers of children with CF, acceptable to them, and rigorously tested for reliability and validity. Using a community-engaged process, we will systematically address these knowledge gaps.